In situ detection of virus-and tumor-specific T-cell immunity

JBAG Haanen, MGCT van Oijen, F Tirion… - Nature Medicine, 2000 - nature.com
JBAG Haanen, MGCT van Oijen, F Tirion, LCJM Oomen, AM Kruisbeek, FA Vyth-Dreese…
Nature Medicine, 2000nature.com
The development of strategies to visualize antigen-specific T-cell responses by flow
cytometry has radically changed our understanding of the dynamics and magnitude of virus-
induced T-cell immunity. Through the use of tetrameric–major histocompatibility complex
(MHC) complexes, massive expansions of antigen-specific CD8+ T cells have been
characterized for a variety of pathogens1–5. In addition, this technique has been used for
the detection of auto-reactive and tumor-reactive T-cell immunity in vitiligo and melanoma …
The development of strategies to visualize antigen-specific T-cell responses by flow cytometry has radically changed our understanding of the dynamics and magnitude of virus-induced T-cell immunity. Through the use of tetrameric–major histocompatibility complex (MHC) complexes, massive expansions of antigen-specific CD8+ T cells have been characterized for a variety of pathogens1–5. In addition, this technique has been used for the detection of auto-reactive and tumor-reactive T-cell immunity in vitiligo and melanoma patients6, 7, demonstrating its value for the detection of low frequencies of self-reactive T cells. Here, we describe the use of MHC tetramers for the direct in situ visualization of antigen-specific T-cell responses. The combined use of MHC tetramer technology and confocal laser scanning microscopy (CLSM) allows detection of both virusand tumor-specific CD8+ T cells in lymphoid organs, peripheral tissues and tumor infiltrates.
nature.com